Method for determining multiple myeloma by assaying for expressi

Details Method for determining multiple myeloma by assaying for expressi Method for determining multiple myeloma by assaying for expressi

1998-02-04

1999-11-16

Marschel, Ardin H.

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving nucleic acid

435 912, 435 5, 536 221, 536 243, C12P 1934, C12Q 168, C12Q 170, C07H 2104

Patent

active

059855711

ABSTRACT:
Methods for diagnosing multiple myeloma are disclosed. These methods are based upon the observation that tumor rejection antigen precursors are expressed in multiple myeloma. By assaying bone marrow samples, one can diagnose multiple myeloma, and also monitor the disease's progress. Therapeutic approaches of multiple myeloma are also disclosed.

REFERENCES:
patent: 5512444 (1996-04-01), Patard et al.
patent: 5612201 (1997-03-01), De Plaen et al.
patent: 5763165 (1998-06-01), Boon-Falleur et al.

Affiliated with

Also associated with

Rating

Method for determining multiple myeloma by assaying for expressi does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for determining multiple myeloma by assaying for expressi, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for determining multiple myeloma by assaying for expressi will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1323010